Shilpa Medicare Limited — Updates, 30-05-2026: General Updates
30-05-2026 | 03:32 pm
30-05-2026 | 03:32 pm
Shilpa Medicare's Bengaluru facility received 5 procedural observations during a USFDA inspection. No data integrity issues or material impact on current business operations or supplies are anticipated. The company will address the observations.
No comments yet. Be the first to comment!
